Table 4.
Clinical outcomes after CKRT
| Patient No. | Tumor type | RT type | Follow up (mos.) | CKRT symptoms | Pre−/Post-CKRT peritumoral edema | Visual function post-CKRT | Olfaction function post-CKRT | Change in tumor size Post-CKRT | Pre−/Post CKRT KPS | Pre−/Post- CKRT median tumor size (cm) |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Primary | SRS | 9 | None | Mild/Slightly increased | Unchanged | Unchanged | Unchanged | 50/50 | 2.50/2.50 |
| 2 | Primary | SRS | 106 | Fatigue | None/None | Unchanged | Unchanged | Decreased | 90/100 | 3.50/2.90 |
| 3 | Primary | SRS | 10 | None | Moderate/Significantly increased | Unchanged | Unchanged | Unchanged | 90/80 | 2.80/2.9 |
| 4 | Primary | SRS | 45 | None | None/None | Unchanged | Unchanged | Unchanged | 100/90 | 1.15/1.06 |
| 5 | Residual | SRS | 60 | None | None/None | Unchanged | Unchanged | Unchanged | 90/90 | 1.80/1.8 |
| 6 | Primary | HSRT | 99 | Fatigue, forgetfulness, hallucinations | Mild / Minimally increased | Unchanged | Unchanged | Unchanged | 90/70 | 2.56/2.49 |
| 7 | Primary | HSRT | 11 | None | Moderate/Minimally increased | Unchanged | Unchanged | Unchanged | 80/80 | 4.49/4.41 |
| 8 | Primary | HSRT | 89 | Fatigue | Moderate/Minimally increased | Unchanged | Unchanged | Decreased | 80/70 | 3.00/2.60 |
| 9 | Primary | HSRT | 47 | None | None/None | Unchanged | Unchanged | Decreased | 100/90 | 1.30/0.93 |
| 10 | Residual | HSRT | 20 | None | Mild/Mild | Improved | Unchanged | Decreased | 90/70 | 3.91/3.33 |
| 11 | Residual | FSRT | 19 | Headaches, fatigue, forgetfulness | None/None | Unchanged | Unchanged | Decreased | 100/90 | 2.00/1.70 |
| 12 | Recurrent | FSRT | 61 | None | without /without | Unchanged | unchanged | Decreased | 100/90 | 1.20/0 |